The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction
Abstract
We reported aldosterone as a novel adipocyte-derived factor that regulates vascular function. We aimed to investigate molecular mechanisms, signaling pathways, and functional significance of adipocyte-derived aldosterone and to test whether adipocyte-derived aldosterone is increased in diabetes mellitus–associated obesity, which contributes to vascular dysfunction. Studies were performed in the 3T3-L1 adipocyte cell line and mature adipocytes isolated from human and mouse (C57BL/6J) adipose tissue. Mesenteric arteries with and without perivascular fat and mature adipocytes were obtained from obese diabetic db/db and control db/+ mice. Aldosterone synthase (CYP11B2; mRNA and protein) was detected in 3T3-L1 and mature adipocytes, which secrete aldosterone basally and in response to angiotensin II (Ang II). In 3T3-L1 adipocytes, Ang II stimulation increased aldosterone secretion and CYP11B2 expression. Ang II effects were blunted by an Ang II type 1 receptor antagonist (candesartan) and inhibitors of calcineurin (cyclosporine A and FK506) and nuclear factor of activated T-cells (VIVIT). FAD286 (aldosterone synthase inhibitor) blunted adipocyte differentiation. In candesartan-treated db/db mice (1 mg/kg per day, 4 weeks) increased plasma aldosterone, CYP11B2 expression, and aldosterone secretion were reduced. Acetylcholine-induced relaxation in db/db mesenteric arteries containing perivascular fat was improved by eplerenone (mineralocorticoid receptor antagonist) without effect in db/+ mice. Adipocytes possess aldosterone synthase and produce aldosterone in an Ang II/Ang II type 1 receptor/calcineurin/nuclear factor of activated T-cells–dependent manner. Functionally adipocyte-derived aldosterone regulates adipocyte differentiation and vascular function in an autocrine and paracrine manner, respectively. These novel findings identify adipocytes as a putative link between aldosterone and vascular dysfunction in diabetes mellitus–associated obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, the increased aldosterone production by adipocytes in obesity was shown to contribute to the vascular changes associated with this condition (54).”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
In the citing paper
“For instance, adipocyte-derived aldosterone has emerged as a new paradigm in linking obesity with vascular disease (54).”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
In the citing paper
“Moreover, this study revealed that adipocyte-derived aldosterone regulates vascular function in a paracrine manner.”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
In the citing paper
“Adipocytes were found to possess the components necessary for aldosterone synthesis.”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
Citations
Cites
Greenstein, A. S., Khavandi, K., Withers, S., Sonoyama, K., Clancy, O., Jeziorska, M., Laing, I., Yates, A. P., Pemberton, P. W., Malik, R. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.821181 · Cited by 616
Interaction of calcineurin with substrates and targeting proteins
Li, H., Rao, A., & Hogan, P. G. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.09.011 · Cited by 381
Guo, C., Ricchiuti, V., Lian, B. Q., Yao, T. M., Coutinho, P., Romero, J. R., Li, J., Williams, G. H., & Adler, G. K. (2008) · Circulation · doi:10.1161/circulationaha.107.748640 · Cited by 342
Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis
Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M.-C. (2007) · The FASEB Journal · doi:10.1096/fj.06-7970com · Cited by 337
The secretory function of adipocytes in the physiology of white adipose tissue
Wang, P., Mariman, E., Renes, J., & Keijer, J. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21386 · Cited by 318
Enhanced Aldosterone Signaling in the Early Nephropathy of Rats with Metabolic Syndrome
Nagase, M., Yoshida, S., Shibata, S., Nagase, T., Gotoda, T., Ando, K., & Fujita, T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080944 · Cited by 247
Hirata, A., Maeda, N., Hiuge, A., Hibuse, T., Fujita, K., Okada, T., Kihara, S., Funahashi, T., & Shimomura, I. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp191 · Cited by 241
Adipogenic and lipolytic effects of chronic glucocorticoid exposure
Campbell, J. E., Peckett, A. J., D'souza, A. M., Hawke, T. J., & Riddell, M. C. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00045.2010 · Cited by 228
Body Mass Index Predicts Aldosterone Production in Normotensive Adults on a High-Salt Diet
Bentley–Lewis, R., Adler, G. K., Perlstein, T. S., Seely, E. W., Hopkins, P. N., Williams, G. H., & Garg, R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1088 · Cited by 213
Ketonen, J., Jin, S., Martonen, E., & Mervaala, E. M. A. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0661 · Cited by 209
The role of perivascular adipose tissue in vascular smooth muscle cell growth
Miao, C., & Li, Z. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01404.x · Cited by 183
Inhibitors of the Calcineurin / NFAT Pathway
Martı́nez-Martı́nez, S., & Redondo, J. M. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455576 · Cited by 172
Endothelium-dependent relaxation factor released by perivascular adipose tissue
Lee, R. M. K. W., Lü, C., Su, L.-Y., & Gao, Y. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328324ed86 · Cited by 163
Perivascular Adipose Tissue and Mesenteric Vascular Function in Spontaneously Hypertensive Rats
Gálvez, B. G., de Castro, J., Herold, D., Dubrovska, G., Arribas, S. M., González, M. C., Aránguez, I., Luft, F. C., Ramos, P., Gollasch, M., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000220381.40739.dd · Cited by 158
Role of Elastin in Spontaneously Hypertensive Rat Small Mesenteric Artery Remodelling
Briones, A. M., González, J. M., Somoza, B., Giraldo, J., Daly, C. J., Vila, E., González, M. C., McGrath, J. C., & Arribas, S. M. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.046904 · Cited by 146
Self-citationCaprio, M., Antelmi, A., Chetrite, G., Muscat, A., Mammi, C., Marzolla, V., Fabbri, A., Zennaro, M., & Fève, B. (2010) · Endocrinology · doi:10.1210/en.2010-0674 · Cited by 139
Guzik, T. J., Marvar, P. J., Czesnikiewicz-Guzik, M., & Korbut, R. (2007) · PubMed · Cited by 128
Hoppmann, J., Perwitz, N., Meier, B., Faßhauer, M., Hadaschik, D., Lehnert, H., & Klein, J. C. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0292 · Cited by 125
Ho, I., Kim, J. H.-J., Rooney, J. W., Spiegelman, B. M., & Glimcher, L. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15537 · Cited by 123
Inflamed adipose tissue, insulin resistance and vascular injury
Andersson, C. X., Gustafson, B., Hammarstedt, A., Hedjazifar, S., & Smith, U. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.889 · Cited by 118
Withers, S., Rosei, C. A., Livingstone, D. M., Little, M. C., Aslam, R., Malik, R. A., & Heagerty, A. M. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.221705 · Cited by 118
The adipose renin–angiotensin system: Role in cardiovascular disease
Thatcher, S. E., Yiannikouris, F. B., Gupte, M., & Cassis, L. A. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.01.019 · Cited by 110
Adipokines and blood pressure control
Yiannikouris, F. B., Gupte, M., Putnam, K., & Cassis, L. A. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283366cd0 · Cited by 98
Schinner, S., Willenberg, H. S., Krause, D., Schott, M., Lamounier‐Zepter, V., Krug, A. W., Ehrhart‐Bornstein, M., Bornstein, S. R., & Scherbaum, W. A. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803508 · Cited by 89
Cat, A. N. D., Briones, A. M., Callera, G. E., Yogi, Á., He, Y., Montezano, A. C. I., & Touyz, R. M. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168872 · Cited by 84
Self-citationEhrhart‐Bornstein, M., Arakelyan, K., Krug, A. W., Scherbaum, W. A., & Bornstein, S. R. (2004) · Endocrine Research · doi:10.1081/erc-200044122 · Cited by 80
Jiménez‐Altayó, F., Briones, A. M., Giraldo, J., Planas, A. M., Salaíces, M., & Vila, E. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088435 · Cited by 75
Self-citationThe Role of Aldosteronism in Causing Obesity-Related Cardiovascular Risk
Calhoun, D. A., & Sharma, K. (2010) · Cardiology Clinics · doi:10.1016/j.ccl.2010.04.001 · Cited by 74
Xavier, F. E., Aras‐López, R., Arroyo-Villa, I., del Campo, L., Salaíces, M., Rossoni, L. V., Ferrer, M., & Balfagón, G. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.200 · Cited by 73
Blockade of AT1 Receptor Improves Adipocyte Differentiation in Atherosclerotic and Diabetic Models
Tomono, Y., Iwai, M., Inaba, S., Mogi, M., & Horiuchi, M. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2007.50 · Cited by 72
Mineralocorticoid Receptor Antagonists and the Metabolic Syndrome
Tirosh, A., Garg, R., & Adler, G. K. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0126-2 · Cited by 72
Suzuki, E., Nishimatsu, H., Satonaka, H., Walsh, K., Goto, A., Omata, M., Fujita, T., Nagai, R., & Hirata, Y. (2002) · Circulation Research · doi:10.1161/01.res.0000017629.70769.cc · Cited by 70
Dall’Asta, C., Vedani, P., Manunta, P., Pizzocri, P., Marchi, M., Paganelli, M., Folli, F. B., & Pontiroli, A. E. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.06.001 · Cited by 67
Wong, W. T., Tian, X. Y., Xu, A., Ng, C., Lee, H. K., Chen, Z., Au, C. L., Yao, X., & Huang, Y. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2831 · Cited by 62
Cat, A. N. D., Ouvrard‐Pascaud, A., Tronche, F., Clemessy, M., González-Núñez, D., Farman, N., & Jaisser, F. (2008) · Endocrinology · doi:10.1210/en.2008-1531 · Cited by 36
Mineralocorticoid-stimulating activity of adipose tissue
Lamounier‐Zepter, V., Ehrhart‐Bornstein, M., & Bornstein, S. R. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.002 · Cited by 35
Yamashiro, T., Kuge, H., Zhang, J., & Honke, K. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvq037 · Cited by 16
Pleiotropic Effects of ARB in Metabolic Syndrome
Yamada, S. (2011) · Current Vascular Pharmacology · doi:10.2174/157016111794519318 · Cited by 15
Nithipatikom, K., Holmes, B. B., Isbell, M. A., Hanke, C. J., Gómez-Sánchez, C. E., & Campbell, W. B. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.11.025 · Cited by 13
Cited by
Sorted by citations
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889
RetractedPacker, M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.509 · Cited by 656
Effects of Exercise to Improve Cardiovascular Health
Pinckard, K. M., Baskin, K. K., & Stanford, K. I. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00069 · Cited by 517
Obesity and Cardiometabolic Risk Factors: From Childhood to Adulthood
Drożdż, D., Pitti, J. Á., Wójcik, M., Borghi, C., Gabbianelli, R., Mazur, A., Herceg-Čavrak, V., López‐Valcárcel, B. G., Brzeziński, M., Lurbe, E., et al. (2021) · Nutrients · doi:10.3390/nu13114176 · Cited by 441
Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications
Harvey, A., Montezano, A. C. I., Alves-Lopes, R., Rios, F. J. O., & Touyz, R. M. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.070 · Cited by 385
Self-citation
Metadata
- Authors
- Briones, A. M., Nguyen Dinh Cat, A., Callera, G. E., Yogi, A., Burger, D., He, Y., Corrêa, J. W., Gagnon, A. M., Gomez-Sanchez, C. E., Gomez-Sanchez, E. P., Sorisky, A., Ooi, T. C., Ruzicka, M., Burns, K. D., & Touyz, R. M.
- Affiliations
- University of Ottawa (CA)
- From the Kidney Research Centre (A.M.B., A.N.D.C., G.E.C., A.Y., D.B., Y.H., J.W.C., K.D.B., R.M.T.), Chronic Disease Program (A.M.G., A.S., T.C.O.), Ottawa Hospital Research Institute, and Division of Nephrology, Department of Medicine (M.R.), University of Ottawa, Ontario, Canada; G.V. (Sonny) Montgomery Veterans Affairs and Division of Endocrinology, Department of Medicine, University of Mississippi Medical Centers, Jackson, MS (C.E.G.-S., E.P.G.-S.); Current address (A.M.B.): Departamento...
- ORCID
- Venue
- Hypertension
- Published
- 2012-05
- Volume
- 59
- Issue
- 5
- Pages
- 1069-1078
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2111017518
- Cited by
- 375
- References
- 39
- Citations by year
- 2026: 24 · 2025: 29 · 2024: 26 · 2023: 30 · 2022: 18 · 2021: 28 · 2020: 22 · 2019: 19 · 2018: 27 · 2017: 21 · 2016: 27 · 2015: 35 · 2014: 32 · 2013: 27 · 2012: 10
- FWCI
- 26.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- aldosterone synthase, calcineurin, NFAT, angiotensin II, angiotensin II type 1 receptor, adipogenesis, vascular dysfunction, db/db mice, perivascular adipose tissue, mesenteric arteries, acetylcholine-induced relaxation, mineralocorticoid receptor, candesartan, eplerenone, autocrine and paracrine signaling
- MeSH terms
- Aldosterone, Animals, Benzimidazoles, Biphenyl Compounds, Cells, Cultured, Diabetic Angiopathies, Disease Models, Animal, Humans, Mice, Inbred C57BL, Obesity, Random Allocation, Sensitivity and Specificity, Tetrazoles, Signal Transduction, Adipocytes, Calcineurin, Diabetes Complications, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review